Legacy Wealth Asset Management LLC Takes Position in Synopsys, Inc. $SNPS

Legacy Wealth Asset Management LLC purchased a new stake in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 3,036 shares of the semiconductor company’s stock, valued at approximately $1,498,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Symphony Financial Ltd. Co. increased its stake in shares of Synopsys by 4,780.9% during the 2nd quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock worth $20,638,000 after purchasing an additional 39,395 shares during the last quarter. HBW Advisory Services LLC lifted its stake in Synopsys by 494.9% in the second quarter. HBW Advisory Services LLC now owns 3,611 shares of the semiconductor company’s stock valued at $1,851,000 after purchasing an additional 3,004 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in Synopsys by 0.4% during the second quarter. Bank of New York Mellon Corp now owns 1,347,887 shares of the semiconductor company’s stock valued at $691,035,000 after purchasing an additional 4,815 shares during the period. Westbourne Investments Inc. bought a new position in Synopsys during the second quarter valued at $1,505,000. Finally, Mirae Asset Global Investments Co. Ltd. grew its holdings in Synopsys by 1.7% during the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 178,786 shares of the semiconductor company’s stock valued at $91,660,000 after purchasing an additional 2,991 shares during the period. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on SNPS. Zacks Research raised Synopsys from a “strong sell” rating to a “hold” rating in a research report on Monday, November 10th. Stifel Nicolaus lowered their price objective on Synopsys from $650.00 to $550.00 and set a “buy” rating on the stock in a research note on Wednesday, September 10th. Needham & Company LLC increased their target price on shares of Synopsys from $550.00 to $580.00 and gave the stock a “buy” rating in a research report on Thursday, December 11th. Wall Street Zen upgraded shares of Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Synopsys in a research note on Wednesday, October 8th. Eleven investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $562.13.

Get Our Latest Stock Analysis on Synopsys

Synopsys News Roundup

Here are the key news stories impacting Synopsys this week:

  • Positive Sentiment: KeyCorp reiterated bullish coverage and published multi‑year EPS projections and a $600 price target, which supports upside expectations for SNPS and likely helped buying interest. KeyCorp estimates and MarketBeat summary
  • Neutral Sentiment: Zacks and other outlets note elevated investor attention in SNPS; increased retail/institutional focus can amplify moves in either direction but does not by itself change fundamentals. Zacks: Investor Attention
  • Neutral Sentiment: MarketWatch flagged that SNPS underperformed peers on a relative basis despite daily gains — a reminder that sector rotation and peer performance are constraining factors. MarketWatch: Relative Performance
  • Negative Sentiment: Multiple securities‑fraud class‑action notices and law‑firm solicitations have been filed or distributed, alleging material misstatements for purchases made between Dec. 4, 2024 and Sept. 9, 2025; the widely publicized Dec. 30, 2025 lead‑plaintiff deadline increases headline risk and potential legal exposure. GlobeNewswire: Class Action Filed
  • Negative Sentiment: Several plaintiff firms (Rosen, Levi & Korsinsky, Faruqi & Faruqi, Bleichmar Fonti & Auld, Schall, Gross, etc.) are soliciting lead‑plaintiff applications — this broad outreach typically precedes contested litigation phases that can drive volatility and potentially settlement costs or reputational damage. Example notice: Rosen Law Firm: Final Deadline Notice

Synopsys Stock Up 1.2%

SNPS stock opened at $463.73 on Monday. The stock has a 50-day simple moving average of $434.19 and a two-hundred day simple moving average of $504.21. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $651.73. The firm has a market capitalization of $86.14 billion, a PE ratio of 58.04, a PEG ratio of 3.86 and a beta of 1.16. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48.

Synopsys (NASDAQ:SNPSGet Free Report) last released its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, beating analysts’ consensus estimates of $2.79 by $0.11. The company had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. Synopsys’s revenue was up 37.8% compared to the same quarter last year. During the same period last year, the business earned $3.40 earnings per share. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, equities analysts predict that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Featured Articles

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.